A
Anil K. Patri Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
High Impact
Research Scholar
faculty
39 h-index
103 pubs
11,901 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Anil K. Patri's research focuses on the regulatory science and toxicological assessment of emerging technologies, particularly nanoparticles and microplastics. His work investigates the characterization, identification, and quantitation of these materials, with a focus on their potential impact on human and animal health.
His recent publications explore the regulatory landscape of nanotechnology and nanoplastics from a global perspective, the analysis of microplastics and nanoplastics in food, and the development of practical synthesis methods for carbon quantum dots with potential bioimaging applications. Patri has also published on the effects of specific nanomaterials, such as titanium dioxide and silver nanoparticles, on biological systems, including DNA methylation in human cells and the reproductive tract of female rats. His research also includes the optimization of detection methods for substances like gadodiamide in rats using advanced imaging techniques.
Patri holds a designation as a high-impact researcher due to his extensive publication record, which includes 105 publications and over 11,700 citations, with an h-index of 39. He maintains an active research group and collaborates with several researchers at the National Center for Toxicological Research, including Sanghamitra Majumdar, Tariq Fahmi, Weida Tong, and William Slikker.
Metrics
- h-index: 39
- Publications: 103
- Citations: 11,901
Selected Publications
-
Evaluation of sources of variability in a nitric oxide screening assay for engineered nanomaterials (2025)
-
Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells (2024)
-
Biodistribution and toxic potential of silver nanoparticles when introduced to the female rat reproductive tract (2024)
-
Regulatory Science Perspective on the Analysis of Microplastics and Nanoplastics in Human Food (2024)
-
Comprehensive analysis of common polymers using hyphenated TGA-FTIR-GC/MS and Raman spectroscopy towards a database for micro- and nanoplastics identification, characterization, and quantitation (2023)
-
Nanotechnology in vaccines and personalized medicine (2023)
-
Radiation impacts on toxicity of cobalt–chromium (CoCr) implant debris (2023)
-
Optimization of Detection of Gadodiamide Brain Retention in Rats Using Quantitative <scp>T<sub>2</sub></scp> Mapping and Intraperitoneal Administration (2022)
-
Regulatory landscape of nanotechnology and nanoplastics from a global perspective (2021)
Collaboration Network
Top Collaborators
Richard W. Ahn
Northwestern University (US)
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Haimei Chen
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Stęphan T. Stern
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Jeffrey D. Clogston
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Meera R. Raja
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Elden P. Swindell
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Vamsi Parimi
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Vincent L. Cryns
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Thomas V. O’Halloran
4 shared publications
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Ravindra R. Kamble
Karnatak University (IN)
3 shared publications
- A Practical green synthesis for fluorescence carbon quantum dots via red Aloe barbadensis miller: antioxidant, anticancer and potential bioimaging applications
- Development of Novel MoS <sub>2</sub> /Carbon‐Based Electrochemical Sensor for Ultra‐Trace Level Detection of Tryptophan in Real Samples
- Multicomponent synthesis of imidazol-1-yl-5-oxo-1,2,4-triazol-4-yl-benzoic acids from N-carboxyphenyl sydnone as novel dyes for dye sensitized solar cells
Vishwa B. Nadoni
Karnatak University (IN)
3 shared publications
- A Practical green synthesis for fluorescence carbon quantum dots via red Aloe barbadensis miller: antioxidant, anticancer and potential bioimaging applications
- Development of Novel MoS <sub>2</sub> /Carbon‐Based Electrochemical Sensor for Ultra‐Trace Level Detection of Tryptophan in Real Samples
- Multicomponent synthesis of imidazol-1-yl-5-oxo-1,2,4-triazol-4-yl-benzoic acids from N-carboxyphenyl sydnone as novel dyes for dye sensitized solar cells
Manojna R. Nayak
Karnatak University (IN)
3 shared publications
- A Practical green synthesis for fluorescence carbon quantum dots via red Aloe barbadensis miller: antioxidant, anticancer and potential bioimaging applications
- Development of Novel MoS <sub>2</sub> /Carbon‐Based Electrochemical Sensor for Ultra‐Trace Level Detection of Tryptophan in Real Samples
- Multicomponent synthesis of imidazol-1-yl-5-oxo-1,2,4-triazol-4-yl-benzoic acids from N-carboxyphenyl sydnone as novel dyes for dye sensitized solar cells
Arnd Hoeveler
Joint Research Centre (DE)
2 shared publications
- Regulatory landscape of nanotechnology and nanoplastics from a global perspective
- Emerging technologies and their impact on regulatory science
Marta Hugas
European Food Safety Authority (IT)
2 shared publications
- Regulatory landscape of nanotechnology and nanoplastics from a global perspective
- Emerging technologies and their impact on regulatory science
Elke Anklam
Joint Research Centre (DE)
2 shared publications
- Regulatory landscape of nanotechnology and nanoplastics from a global perspective
- Emerging technologies and their impact on regulatory science
Similar Researchers
Based on overlapping research topics
Gail Runnels
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Health and Medical Research Impacts
Carcinogens and Genotoxicity Assessment
Arjun Sharmah
National Center for Toxicological Research
Nanoparticles: synthesis and applications
Pharmacological Effects and Toxicity Studies
Carcinogens and Genotoxicity Assessment
Michael J. Norvell
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Health and Medical Research Impacts
Carcinogens and Genotoxicity Assessment
Fred A. Hines
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Health and Medical Research Impacts
Carcinogens and Genotoxicity Assessment
Huixiao Hong
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Health and Medical Research Impacts
Carcinogens and Genotoxicity Assessment
Veronica L. Call
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Health and Medical Research Impacts
Carcinogens and Genotoxicity Assessment